TI
ACIU icon

Trexquant Investment’s AC Immune ACIU Stock Holding History

Trexquant Investment’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,643
Closed -$108K – 1085
2021
Q2 		$108K Buy
+13,643
New +$94.3K 0.01% 1010
2020
Q1 		– Sell
-29,092
Closed -$248K – 1057
2019
Q4 		$248K Buy
+29,092
New +$194K 0.01% 825
2019
Q1 		– Sell
-49,544
Closed -$468K – 953
2018
Q4 		$468K Buy
+49,544
New +$468K 0.03% 629

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Trexquant Investment's ACIU Position: Q3 2021 in Review

Trexquant Investment sold out of AC Immune (ACIU) in Q3 2021, closing a stake of 13,643 shares — an estimated $108K sold.

Trexquant Investment first reported a position in ACIU in Q4 2018 and held it in 3 quarters. The position peaked at $468K in Q4 2018. 64 funds tracked by Wall St. Rank hold ACIU as of Q3 2021.

  • Trexquant Investment reported no remaining AC Immune position as of Q3 2021 after selling out during the quarter.
  • Trexquant Investment sold 13,643 AC Immune shares in Q3 2021, an estimated $108K.
  • Trexquant Investment first reported a position in AC Immune in Q4 2018 and held it in 3 quarters.
  • Trexquant Investment's AC Immune position peaked at $468K in Q4 2018.
  • 64 funds tracked by Wall St. Rank held AC Immune as of Q3 2021.

Based on Trexquant Investment's 13F filing for Q3 2021, filed 12 Nov 2021.